
Asthma Devices Market Trends
Asthma Device Market Research Report Information By Type (Inhalers, Nebulizers, Dry Powder Inhalers, Metered-Dose Inhalers, Mesh Nebulizers) By Technology (Manually Operated, Digitally Operated) By End Users (Hospital, Retail Pharmacies)-Forecast till 2035

Market Summary
The Global Asthma Devices Market is projected to grow from 4.21 USD Billion in 2024 to 8.6 USD Billion by 2035, reflecting a robust growth trajectory.
Key Market Trends & Highlights
Global Asthma Devices Key Trends and Highlights
- The market is expected to achieve a compound annual growth rate (CAGR) of 6.71% from 2025 to 2035.
- By 2035, the market valuation is anticipated to reach 8.6 USD Billion, indicating substantial growth potential.
- In 2024, the market is valued at 4.21 USD Billion, laying a solid foundation for future expansion.
- Growing adoption of advanced inhalation technologies due to increasing prevalence of asthma is a major market driver.
Market Size & Forecast
2024 Market Size | 4.21 (USD Billion) |
2035 Market Size | 8.6 (USD Billion) |
CAGR (2025-2035) | 6.71% |
Largest Regional Market Share in 2024 | south_america) |
Major Players
GlaxoSmithKline plc., Merck & Co., Inc., 3M, Aristopharma Ltd., SRS PHARMACEUTICALS PVT. LTD., AstraZeneca, Baxter, Boehringer Ingelheim GmbH, Koninklijke Philips N.V.
Market Trends
The increasing prevalence of asthma globally, coupled with advancements in device technology, suggests a robust growth trajectory for the asthma devices market, driven by the need for effective management solutions.
World Health Organization (WHO)
Asthma Devices Market Market Drivers
Rising Prevalence of Asthma
The increasing prevalence of asthma globally serves as a primary driver for the Global Global Asthma Devices Market Industry. According to health statistics, asthma affects approximately 300 million individuals worldwide, with numbers expected to rise. This growing patient population necessitates the development and distribution of effective asthma management devices. The market is projected to reach 4.21 USD Billion in 2024, reflecting the urgent need for innovative solutions. As awareness of asthma management improves, the demand for devices such as inhalers and nebulizers is likely to increase, further propelling market growth.
Market Segment Insights
On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.
Asthma Devices Technology Insights
On the basis of technology, the asthma devices market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others.
Asthma Devices End-User Insights
On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.
Get more detailed insights about Asthma Devices Market Research Report – Forecast till 2032
Regional Insights
Key Companies in the Asthma Devices Market market include


Industry Developments
Future Outlook
Asthma Devices Market Future Outlook
The Global Asthma Devices Market is projected to grow at a 6.71% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of asthma, and rising healthcare expenditure.
New opportunities lie in:
- Develop smart inhalers with integrated digital health solutions for real-time monitoring.
- Expand product lines to include eco-friendly, sustainable asthma devices.
- Leverage telemedicine platforms to enhance patient engagement and adherence to treatment.
By 2035, the market is expected to exhibit robust growth, reflecting advancements in asthma management technologies.
Market Segmentation
Report Scope
Attribute/Metric | Details |
Market Size 2023 | 4 (USD Billion) |
Market Size 2024 | 4.21 (USD Billion) |
Market Size 2032 | 7.45 (USD Billion) |
Compound Annual Growth Rate (CAGR) | 4.89 % (2024 - 2032) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year | 2023 |
Market Forecast Period | 2024 - 2032 |
Historical Data | 2019 - 2023 |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter. (U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others |
Key Market Opportunities | The Americas dominate the global asthma devices market owing to a well-developed healthcare sector and huge patient population for asthma diseases |
Key Market Drivers | Increasing prevalence of asthma |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
-
TABLE OF CONTENT
-
Chapter 1. Report Prologue
-
Chapter 2. Market Introduction
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
-
Chapter 3. Research Methodology
- Introduction
- Primary Research
- Secondary research
- Market Size Estimation
-
Chapter 4. Market Dynamics
- Drivers
- Restrains
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends & Assessment
-
Chapter 5. Market Factor Analysis
-
Porters Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
-
Porters Five Forces Analysis
-
Chapter 6. Global Asthma Devices Market, by Type
- Introduction
- Inhalers
-
Market Estimates & Forecast, 2020-2027
-
Metered-Dose Inhalers
- Standard Pressurized Metered-Dose Inhalers
- Dry Powder Inhalers
- Others
-
Nebulizers Market Estimates & Forecast, 2020-2027
- Compressor Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
- Others
- Others
-
Metered-Dose Inhalers
-
Chapter 7. Global Asthma Devices Market, by Technology
- Introduction
- Manually Operated Inhaler Devices Market Estimates & Forecast, 2020-2027
- Digitally Operated Inhaler Devices Market Estimates & Forecast, 2020-2027
- Others
-
Chapter 8. Global Asthma Devices Market, by End Users
- Introduction
- Hospitals & Clinics Market Estimates & Forecast, 2020-2027
- Retail Pharmacies Market Estimates & Forecast, 2020-2027
- Home Care Market Estimates & Forecast, 2020-2027
- Others
-
Chapter 9. Global Asthma Devices Market, by Region
- Introduction
-
America
- North America
- South America
-
Europe
- Western Europe
- Eastern Europe
-
Asia Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia Pacific
-
The Middle East & Africa
- United Arab Emirates
- Saudi Arabia
- Oman
- Kuwait
- Qatar
- Rest of the Middle East & Africa
-
Chapter 10. Company Landscape
- Introduction
- Market Share Analysis
-
Key Development & Strategies
- Key Developments
-
Chapter 11 Company Profiles
-
GlaxoSmithKline plc.
- Company Overview
- Type Overview
- Financials
- Key Developments
- SWOT Analysis
-
Merck & Co., Inc.
- Company Overview
- Type Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
3M
- Company Overview
- Type Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
Aristopharma Ltd.
- Company Overview
- Type/Business Segment Overview
- Financial Overview
- Key Development
- SWOT Analysis
-
SRS PHARMACEUTICALS PVT. LTD.
- Company Overview
- Type Overview
- Financial overview
- Key Developments
- SWOT Analysis
-
AstraZeneca
- Company Overview
- Type Overview
- Financial Overview
- Key Developments
- SWOT Analysis
-
Baxter
- Overview
- Type Overview
- Financials
- Key Developments
- SWOT Analysis
-
Boehringer Ingelheim GmbH
- Overview
- Type Overview
- Financials
- Key Developments
- SWOT Analysis
-
Koninklijke Philips N.V.
- Overview
- Type Overview
- Financials
- Key Developments
- SWOT Analysis
- Others
-
GlaxoSmithKline plc.
-
Chapter 12 MRFR Conclusion
-
Key Findings
- From CEO’s View Point
- Unmet Needs of the Market
- Key Companies to Watch
- Prediction of Global Asthma Devices Market
-
Key Findings
-
Chapter 13 Appendix
-
List of Tables and Figures
- LIST OF TABLES
- Table 1 Global Asthma Devices Industry Synopsis, 2020-2027
- Table 2 Global Asthma Devices Market Estimates and Forecast, 2020-2027, (USD Million)
- Table 3 Global Asthma Devices Market by Region, 2020-2027, (USD Million)
- Table 4 Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 5 Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 6 Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 7 North America Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 8 North America Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 9 North America Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 10 U.S. Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 11 U.S. Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 12 U.S. Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 13 Canada Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 14 Canada Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 15 Canada Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 16 South America Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 17 South America Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 18 South America Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 19 Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 20 Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 21 Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 22 Western Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 23 Western Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 24 Western Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 25 Eastern Europe Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 26 Eastern Europe Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 27 Eastern Europe Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 28 Asia Pacific Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 29 Asia Pacific Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 30 Asia Pacific Global Asthma Devices Market by End Users, 2020-2027, (USD Million)
- Table 31 Middle East & Africa Global Asthma Devices Market by Type, 2020-2027, (USD Million)
- Table 32 Middle East & Africa Global Asthma Devices Market by Technology, 2020-2027, (USD Million)
- Table 33 Middle East & Africa Global Asthma Devices Market by End Users, 2020-2027, (USD Million) LIST OF FIGURES
- Figure 1 Research Process
- Figure 2 Segmentation for Global Asthma Devices Market
- Figure 3 Market Dynamics for Global Asthma Devices Market
- Figure 4 Global Asthma Devices Market Share, by Type 2020
- Figure 5 Global Asthma Devices Market Share, by Technology 2020
- Figure 6 Global Asthma Devices Market Share, by End Users, 2020
- Figure 7 Global Asthma Devices Market Share, by Region, 2020
- Figure 8 North America Global Asthma Devices Market Share, by Country, 2020
- Figure 9 Europe Global Asthma Devices Market Share, by Country, 2020
- Figure 10 Asia Pacific Global Asthma Devices Market Share, by Country, 2020
- Figure 11 Middle East & Africa Global Asthma Devices Market Share, by Country, 2020
- Figure 12 Global Asthma Devices Market: Company Share Analysis, 2020 (%)
- Figure 13 GlaxoSmithKline plc.: Key Financials
- Figure 14 GlaxoSmithKline plc.: Segmental Revenue
- Figure 15 GlaxoSmithKline plc.: Geographical Revenue
- Figure 16 Merck & Co., Inc.: Type UK Ltd: Key Financials
- Figure 17 Merck & Co., Inc.: Type UK Ltd: Segmental Revenue
- Figure 18 Merck & Co., Inc.: Type UK Ltd: Geographical Revenue
- Figure 19 3M: Key Financials
- Figure 20 3M: Segmental Revenue
- Figure 21 3M: Geographical Revenue
- Figure 22 Aristopharma Ltd.: Key Financials
- Figure 23 Aristopharma Ltd.: Segmental Revenue
- Figure 24 Aristopharma Ltd.: Geographical Revenue
- Figure 25 SRS PHARMACEUTICALS PVT. LTD.: Key Financials
- Figure 26 SRS PHARMACEUTICALS PVT. LTD.: Segmental Revenue
- Figure 27 SRS PHARMACEUTICALS PVT. LTD.: Geographical Revenue
- Figure 28 AstraZeneca: Key Financials
- Figure 29 AstraZeneca: Segmental Revenue
- Figure 30 AstraZeneca: Geographical Revenue
- Figure 31 Baxter.: Key Financials
- Figure 32 Baxter.: Segmental Revenue
- Figure 33 Baxter.: Geographical Revenue
- Figure 34 Boehringer Ingelheim GmbH: Key Financials
- Figure 35 Boehringer Ingelheim GmbH: Segmental Revenue
- Figure 36 Boehringer Ingelheim GmbH: Geographical Revenue
- Figure 37 Koninklijke Philips N.V.: Key Financials
- Figure 38 Koninklijke Philips N.V.: Segmental Revenue
- Figure 39 Koninklijke Philips N.V.: Geographical Revenue
Asthma Devices Market Segmentation
Market Segmentation Overview
- Detailed segmentation data will be available in the full report
- Comprehensive analysis by multiple parameters
- Regional and country-level breakdowns
- Market size forecasts by segment

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment